Search liu.se

The aims of our research are to uncover the cellular and molecular mechanisms that predispose to systemic and long-term anti-tumor immunity and the mechanisms that drive resistance to immunotherapy.

Cancer is a research network for scientists and health care professionals at Linköping University and at the County Council of Östergötland (Region Östergötland). The research is related to cancer diagnosis, pathogenesis and treatment.

Many pediatric cancer care survivors develop serious cardiovascular complications later in life. The emerging field of computational cardio-oncology leverages advanced data methods to better predict and prevent these complications.

When low doses of cancer drugs are administered continuously near malignant brain tumours using so-called iontronic technology, cancer cell growth drastically decreases. This is demonstrated in experiments with bird embryos.

A study, led by researchers at LiU and Region Östergötland, shows that cancer survivors are at greater risk for cardiovascular diseases, other cancers and other diagnoses later in life.

Mathematical Oncology is an interdisciplinary collaboration to develop direct and inverse mathematical models for brain cancer growth, making use of AI for applications in healthcare.

Linda Bojmar has played a significant role in a groundbreaking study recently published in Nature. The study sheds new light on how cancers in distant organs can profoundly impact liver function, providing crucial insights for cancer treatment.

A certain gene that is passive can cause leucemia or other cancer. But activated, it can increase the response of treatments that are already today in practice.

Growing up just outside of Milan, Claudio Cantù enjoyed a strong passion for sharks and dinosaurs. The fascination for the wonders of nature eventually led him into the world of science - where he is looking for keys to unlock doors to the genome.